Portfolio Manager Factsheet

November 2016

Early in the month we saw the surprise U.S. election results healthcare equities, in particular pharmaceutical and biotechnology stocks rallied, but shortly thereafter weakened to the month end.  Eli Lilly & Co announced final Phase III results for their therapy for the treatment of Alzheimer’s disease.  Unfortunately, the trial failed to show a statistically significant difference compared to a placebo.  

Read more »

Register for email alerts

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.